pot.lu

EU · Pillar explainer

CBD legal status across Luxembourg, Germany, France, and Belgium.

The EU CBD market is fragmented. Here is the practical picture in 2026 for the four countries most relevant to Luxembourg-based buyers and sellers — what is sold openly, what sits in the grey zone, and where the next policy risk is.

Read in: English · Français · Deutsch · Lëtzebuergesch

The 0.3% THC line

The starting point for EU CBD law is the industrial hemp definition: cannabis varieties with no more than 0.3% Δ9-THC are legal to grow, process, and trade. CBD products derived from these varieties are not narcotics, but they are not automatically food, cosmetics, or medicines either — those frameworks impose separate rules.

Country by country

  • Luxembourg — Permissive. Industrial hemp ≤0.3% THC is freely grown, processed, and sold. CBD products are sold openly online and in retail. No medical claims permitted; smokable CBD products are restricted to 18+ under the Tobacco Control Act.
  • Germany — Legal for the substance, restrictive on ingestibles. CBD oils and edibles are treated as Novel Foods under EU Regulation 2015/2283; without an authorised novel-food dossier, sale as food is not lawful. Cosmetics and topicals are sold openly.
  • France — Turbulent. The Conseil d'État ruled in December 2022 that CBD flower and leaf sales cannot be banned, overturning a 2021 government decree. A renewed restriction proposal remains in the EU TRIS notification pipeline; CBD operators should monitor it.
  • Belgium — Restrictive. CBD oils and ingestibles face Novel Food enforcement; CBD-containing tobacco substitutes are prohibited under the 2024 tobacco law. CBD cosmetics are sold without specific restriction.

CBD flower, oil, and cosmetics — three different regimes

It is rarely useful to ask "is CBD legal here?" without specifying the product. Smokable flower sits closest to enforcement risk because it visually overlaps with controlled cannabis. Ingestibles are gated by Novel Food rules. Cosmetics are the easiest category to ship cross-border. Operators selling into multiple EU markets should treat each product category as a separate compliance question.

The France risk

France's proposed restrictions on CBD flower and leaf are the single largest near-term risk for EU CBD publishers and affiliates. If the European Commission accepts a renewed French notification, retail of smokable CBD in France could be re-banned, reducing one of the EU's largest CBD markets and indirectly cooling cross-border demand. Operators reliant on CBD affiliate revenue should diversify into grow accessories, software referrals, or non-CBD content.

Sources

This article is general information, not legal advice. Novel Food positions and national enforcement priorities shift; verify with a regulatory lawyer before launching products.

CBD review series

Independent, affiliate-disclosed reviews of CBD products legally available in the EU.

See the reviews